Ding Baozhu, Geng Songyan, Hou Xiaojie, Ma Xuelian, Xu Huazhou, Yang Fan, Liu Kun, Liang Wenjie, Ma Guoping
College of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050091, Hebei, China.
Hebei Key Laboratory of Integrative Medicine of Liver-Kidney Patterns, Institute of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, China.
Evid Based Complement Alternat Med. 2021 Oct 31;2021:5545193. doi: 10.1155/2021/5545193. eCollection 2021.
To observe the effect of berberine (BBR) on kidney cell pyroptosis in golden hamsters with diabetic nephropathy (DN) and to explore the molecular mechanism of its renal protection.
Fifty clean-grade male golden hamsters were randomly divided into a control group (10) and a model building group (40). The DN model was established by high-sugar and high-fat feeding and injection of a small amount of STZ. After successful establishment of the model, they were randomly divided into a model group, western medicine group, and berberine high- and low-dose groups. The western medicine group was given irbesartan 13.5 mg/kg, and the berberine high- and low-dose groups were given BBR 200 mg/kg and 100 mg/kg, respectively, for 8 consecutive weeks. An automatic biochemical analyser was used to measure blood glucose, blood lipids, kidney function, MDA, and other indicators; radioimmunoassay was used to assess serum insulin; enzyme-linked immunosorbent assay (ELISA) was used to quantify IL-1, IL-6, IL-18, TNF-; HE, PAS, and Masson staining were used to observe kidney pathological tissue morphology; western blot and real-time fluorescent quantitative PCR were used to assess protein and mRNA expression of molecules, such as Nrf2, NLRP3, Caspase-1, and GSDMD; and TUNEL staining was used to detect DNA damage. SPSS statistical software was used for the data analysis.
The kidney tissues of golden hamsters in the control group were normal; Nrf2 was highly expressed, serum MDA level was low, NLRP3 expression in kidney tissue was not obvious, Caspase-1 and GSDMD were weakly expressed, and only a few TUNEL-positive cells were observed. Compared with the control group, the golden hamsters in the model group had obvious renal pathological damage; blood glucose, blood lipids, renal function-related indexes, insulin, and inflammatory factors IL-1, IL-6, IL-18, and TNF- were increased ( < 0.05); NLRP3, Caspase-1, and GSDMD expression was increased; Nrf2 expression was decreased; MDA level was increased ( < 0.05); and the number of TUNEL-positive cells was increased. Compared with the model group, the pathological morphology of the kidney tissue of golden hamsters in the three treatment groups was significantly improved; blood glucose, blood lipids, renal function, and the expression of inflammatory factors IL-1 and IL-6 were reduced ( < 0.05); NLRP3, Caspase-1, GSDMD, and other molecular proteins and mRNA expression were decreased; Nrf2 expression was increased; MDA level was decreased ( < 0.05); and the number of TUNEL-positive cells was decreased.
DN golden hamster kidney NLRP3-Caspase-1-GSDMD signalling was enhanced. BBR can reduce oxidative stress damage by regulating antioxidative Nrf2 and then regulating NLRP3-Caspase-1-GSDMD signalling to inhibit pyroptosis, antagonizing DN inflammation-induced damage.
观察黄连素(BBR)对糖尿病肾病(DN)金黄地鼠肾细胞焦亡的影响,并探讨其肾脏保护作用的分子机制。
将50只清洁级雄性金黄地鼠随机分为对照组(10只)和造模组(40只)。通过高脂高糖喂养并注射少量链脲佐菌素(STZ)建立DN模型。模型成功建立后,将其随机分为模型组、西药组、黄连素高剂量组和低剂量组。西药组给予厄贝沙坦13.5 mg/kg,黄连素高剂量组和低剂量组分别给予BBR 200 mg/kg和100 mg/kg,连续给药8周。采用自动生化分析仪检测血糖、血脂、肾功能、丙二醛(MDA)等指标;采用放射免疫法检测血清胰岛素;采用酶联免疫吸附测定(ELISA)法检测白细胞介素-1(IL-1)、白细胞介素-6(IL-6)、白细胞介素-1β(IL-18)、肿瘤坏死因子-α(TNF-α);采用苏木精-伊红(HE)染色、过碘酸-雪夫(PAS)染色和Masson染色观察肾脏病理组织形态;采用蛋白质免疫印迹法(western blot)和实时荧光定量聚合酶链反应(PCR)检测核因子E2相关因子2(Nrf2)、NOD样受体蛋白3(NLRP3)、半胱天冬酶-1(Caspase-1)、gasdermin D(GSDMD)等分子的蛋白和mRNA表达;采用末端脱氧核苷酸转移酶介导的缺口末端标记(TUNEL)染色检测DNA损伤。采用SPSS统计软件进行数据分析。
对照组金黄地鼠肾脏组织正常;Nrf2高表达,血清MDA水平低,肾组织中NLRP3表达不明显,Caspase-1和GSDMD弱表达,仅观察到少数TUNEL阳性细胞。与对照组相比,模型组金黄地鼠肾脏病理损害明显;血糖、血脂、肾功能相关指标、胰岛素及炎症因子IL-1、IL-6、IL-18、TNF-α升高(P<0.05);NLRP3、Caspase-1、GSDMD表达升高;Nrf2表达降低;MDA水平升高(P<0.05);TUNEL阳性细胞数量增加。与模型组相比,三个治疗组金黄地鼠肾组织病理形态均明显改善;血糖、血脂、肾功能及炎症因子IL-1、IL-6表达降低(P<0.05);NLRP3、Caspase-1、GSDMD等分子蛋白及mRNA表达降低;Nrf2表达升高;MDA水平降低(P<0.05);TUNEL阳性细胞数量减少。
DN金黄地鼠肾NLRP3-Caspase-1-GSDMD信号通路增强。BBR可通过调节抗氧化因子Nrf2降低氧化应激损伤,进而调节NLRP3-Caspase-1-GSDMD信号通路抑制焦亡,拮抗DN炎症所致损伤。